Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
TRAPPC2
Introduction
Trafficking protein particle complex subunit 2 (TRAPPC2) also known as MBP-1-interacting protein 2A (MIP-2A) is a protein that in humans is encoded by the TRAPPC2 gene.[1][2] A processed pseudogene of this gene is located on chromosome 19, and other pseuodogenes of it are found on chromosome 8 and the Y chromosome. Two transcript variants encoding the same protein have been found for this gene.[2]
Function
Function
Trafficking protein particle complex subunit 2 is thought to be part of a large multisubunit complex involved in the targeting and fusion of endoplasmic reticulum-to-Golgi transport vesicles with their acceptor compartment. In addition, the encoded protein can bind MBP1 and block its transcriptional repression capability.[2]
Genetic Location
Genetic Location
The TRAPPC2 gene is located on the X-chromosome at position 22 between base-pairs 13,712,241 to 13,734,634.[3]
Clinical significance
Clinical significance
Mutations in this gene are a cause of X-linked spondyloepiphyseal dysplasia tarda (SEDT).[2]
References
References
- ↑ Gecz J, Shaw MA, Bellon JR, de Barros Lopes M (November 2003). “Human wild-type SEDL protein functionally complements yeast Trs20p but some naturally occurring SEDL mutants do not”. Gene. 320: 137–44. doi:10.1016/S0378-1119(03)00819-9. PMID 14597397.
- ↑ 2.0 2.1 2.2 2.3 “Entrez Gene: TRAPPC2 trafficking protein particle complex 2”.
- ↑ “TRAPPC2 gene at Genetics Home Reference”.
- ↑ Ghosh, A K; Majumder M; Steele R; White R A; Ray R B (January 2001). “A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1”. Mol. Cell. Biol. UNITED STATES. 21 (2): 655–62. doi:10.1128/MCB.21.2.655-662.2001. ISSN 0270-7306. PMC 86643. PMID 11134351.
- ↑ Fan, Libin; Yu Wei; Zhu Xueliang (April 2003). “Interaction of Sedlin with chloride intracellular channel proteins”. FEBS Lett. Netherlands. 540 (1–3): 77–80. doi:10.1016/S0014-5793(03)00228-X. ISSN 0014-5793. PMID 12681486.
Further reading
Further reading
- Shaw MA, Brunetti-Pierri N, Kádasi L, et al. (2004). “Identification of three novel SEDL mutations, including mutation in the rare, non-canonical splice site of exon 4”. Clin. Genet. 64 (3): 235–42. doi:10.1034/j.1399-0004.2003.00132.x. PMID 12919139.
- Adams MD, Soares MB, Kerlavage AR, et al. (1993). “Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library”. Nat. Genet. 4 (4): 373–80. doi:10.1038/ng0893-373. PMID 8401585.
- Bernard LE, Chitayat D, Weksberg R, et al. (1996). “Linkage analysis of two Canadian families segregating for X linked spondyloepiphyseal dysplasia”. J. Med. Genet. 33 (5): 432–4. doi:10.1136/jmg.33.5.432. PMC 1050619. PMID 8733060.
- Bonaldo MF, Lennon G, Soares MB (1997). “Normalization and subtraction: two approaches to facilitate gene discovery”. Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
- Gedeon AK, Colley A, Jamieson R, et al. (1999). “Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda”. Nat. Genet. 22 (4): 400–4. doi:10.1038/11976. PMID 10431248.
- Gécz J, Hillman MA, Gedeon AK, et al. (2001). “Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda”. Genomics. 69 (2): 242–51. doi:10.1006/geno.2000.6326. PMID 11031107.
- Ghosh AK, Majumder M, Steele R, et al. (2001). “A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1”. Mol. Cell. Biol. 21 (2): 655–62. doi:10.1128/MCB.21.2.655-662.2001. PMC 86643. PMID 11134351.
- Gedeon AK, Tiller GE, Le Merrer M, et al. (2001). “The molecular basis of X-linked spondyloepiphyseal dysplasia tarda”. Am. J. Hum. Genet. 68 (6): 1386–97. doi:10.1086/320592. PMC 1226125. PMID 11349230.
- Grunebaum E, Arpaia E, MacKenzie JJ, et al. (2001). “A missense mutation in the SEDL gene results in delayed onset of X linked spondyloepiphyseal dysplasia in a large pedigree”. J. Med. Genet. 38 (6): 409–11. doi:10.1136/jmg.38.6.409. PMC 1734897. PMID 11424925.
- Mumm S, Zhang X, Vacca M, et al. (2001). “The sedlin gene for spondyloepiphyseal dysplasia tarda escapes X-inactivation and contains a non-canonical splice site”. Gene. 273 (2): 285–93. doi:10.1016/S0378-1119(01)00571-6. PMID 11595175.
- Gavin AC, Bösche M, Krause R, et al. (2002). “Functional organization of the yeast proteome by systematic analysis of protein complexes”. Nature. 415 (6868): 141–7. doi:10.1038/415141a. PMID 11805826.
- Takahashi T, Takahashi I, Tsuchida S, et al. (2003). “An SEDL gene mutation in a Japanese kindred of X-linked spondyloepiphyseal dysplasia tarda”. Clin. Genet. 61 (4): 319–20. doi:10.1034/j.1399-0004.2002.610416.x. PMID 12030902.
- Fiedler J, Bittner M, Puhl W, Brenner RE (2003). “Mutations in the X-linked spondyloepiphyseal dysplasia tarda (SEDL) coding sequence are not a common cause of early primary osteoarthritis in men”. Clin. Genet. 62 (1): 94–5. doi:10.1034/j.1399-0004.2002.620114.x. PMID 12123495.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gao C, Luo Q, Wang HL, et al. (2003). “[Identification of a novel mutation IVS2-2A–>C of SEDL gene in a Chinese family with X-linked spondyloepiphyseal dysplasia tarda]”. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 20 (1): 15–8. PMID 12579492.
- Xiao C, Zhang S, Wang J, et al. (2003). “A single nucleotide deletion of 293delT in SEDL gene causing spondyloepiphyseal dysplasia tarda in a four-generation Chinese family”. Mutat. Res. 525 (1–2): 61–5. doi:10.1016/s0027-5107(02)00315-9. PMID 12650905.
- Fan L, Yu W, Zhu X (2003). “Interaction of Sedlin with chloride intracellular channel proteins”. FEBS Lett. 540 (1–3): 77–80. doi:10.1016/S0014-5793(03)00228-X. PMID 12681486.
- Savarirayan R, Thompson E, Gécz J (2004). “Spondyloepiphyseal dysplasia tarda (SEDL, MIM #313400)”. Eur. J. Hum. Genet. 11 (9): 639–42. doi:10.1038/sj.ejhg.5201025. PMID 12939648.